Background Non-adherence negatively affects the efficacy, safety and costs of therapies.
Non-adherence is a multifactorial problem. This systematic review (SR) of SRs (overview) …

Although advances in care have spurred improvements in cardiovascular outcomes,
cardiovascular disease remains the leading cause of death in the United States and around …

PURPOSE Although we know that racial and ethnic minorities are more likely to have
mistrust in the health care system, very limited knowledge exists on correlates of such …

Two previous pan-European consensus meetings, the 1995 and 2006 Helsingborg
meetings, were convened to review the scientific evidence and the state of current services …

2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

5.1. Wpływ stylu życia na stężenie cholesterolu całkowitego i stężenie cholesterolu frakcji
lipoprotein o małej gęstości................................ 1259 5.2. Wpływ stylu życia na stężenie …

Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

874 Circulation September 1, 2015 references are intended to be illustrative and to highlight
significant knowledge in the field. The premise underlying this scientific statement is that, at …

What happens when patients suddenly stop their medications? We study the health
consequences of drug interruptions caused by large, abrupt, and arbitrary changes in price …

Importance Statins decrease mortality in those with atherosclerotic cardiovascular disease
(ASCVD), but statin adherence remains suboptimal. Objective To determine the association …